12:00 AM
 | 
Oct 07, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Metaxalone SoluMatrix tablets: Phase I data

iCeutica reported top-line data from a 4-way crossover, U.S. Phase I trial in 20 healthy volunteers showing that ICE 1201 had improved oral bioavailability and more rapid absorption compared to Skelaxin metaxalone. ICE 1201 was well tolerated with only...

Read the full 181 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >